Characteristics and management of ocular sarcoidosis

References

• Ungprasert P, Tooley AA, Crowson CS, et al. Clinical characteristics of ocular sarcoidosis: a population-based study 1976-2013. Ocul Immunol Inflamm. 2019;27(3):389–395.
   PubMed Web of Science ®Google Scholar
• Obenauf CD, Shaw HE, Sydnor CF, et al. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol. 1978;86(5):648–655.
   PubMed Web of Science ®Google Scholar
• Crick RP, Hoyle C, Smellie H. The eyes in sarcoidosis. Br J Ophthalmol. 1961;45(7):461–481.
   PubMedGoogle Scholar
• Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol. 1986;102(3):297–301.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509–516.
   PubMed Web of Science ®Google Scholar
• Sonoda KH, Hasegawa E, Namba K, JOIS (Japanese Ocular Inflammation Society) Uveitis Survey Working Group, et al. Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey. Jpn J Ophthalmol. 2021;65(2):184–190.
   PubMed Web of Science ®Google Scholar
• Goto H, Mochizuki M, Yamaki K, et al. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol. 2007;51(1):41–44.
   PubMed Web of Science ®Google Scholar
• Ohguro N, Sonoda KH, Takeuchi M, et al. The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol. 2012;56(5):432–435.
   PubMed Web of Science ®Google Scholar
• Bajwa A, Osmanzada D, Osmanzada S, et al. Epidemiology of uveitis in the mid-Atlantic United States. Clin Ophthalmol. 2015;9:889–901.
   PubMed Web of Science ®Google Scholar
• Tran VT, Auer C, Guex-Crosier Y, et al. Epidemiology of uveitis in Switzerland. Ocul Immunol Inflamm. 1994;2(3):169–176.
   PubMedGoogle Scholar
• Kawaguchi T, Hanada A, Horie S, et al. Evaluation of characteristic ocular signs and systemic investigations in ocular sarcoidosis patients. Jpn J Ophthalmol. 2007;51(2):121–126.
   PubMed Web of Science ®Google Scholar
• Acharya NR, Browne EN, Rao N, International Ocular Sarcoidosis Working Group, et al. Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients. Ophthalmology. 2018;125(1):119–126.
   PubMed Web of Science ®Google Scholar
• Adrianto I, Lin CP, Hale JJ, et al. Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility. PLoS One. 2012;7(8):e43907:
   PubMed Web of Science ®Google Scholar
• Meguro A, Ishihara M, Petrek M, et al. Genetic control of CCL24, POR, and IL23R contributes to the pathogenesis of sarcoidosis. Commun Biol. 2020;3(1):465.
   Web of Science ®Google Scholar
• Fang C, Huang H, Xu Z. Immunological evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. PLoS One. 2016;11(8):e0154716.
   PubMed Web of Science ®Google Scholar
• Lee H, Eom M, Kim SH, et al. Identification of Mycobacterium tuberculosis and non-tuberculous mycobacteria from cutaneous sarcoidosis lesions by reverse blot hybridization assay. J Dermatol. 2019;46(10):917–921.
   Web of Science ®Google Scholar
• Li QH, Zhang Y, Zhao MM, et al. Simultaneous amplification and testing method for Mycobacterium tuberculosis rRNA to differentiate sputum-negative tuberculosis from sarcoidosis. Am J Physiol Lung Cell Mol Physiol. 2019;316(3):L519–l524.
   Web of Science ®Google Scholar
• Uzun L, Savranlar A, Altin R, et al. Mumps virus: a trigger for sarcoidosis? Sarcoidosis Vasc Diffuse Lung Dis. 2004;21(3):237.
   Web of Science ®Google Scholar
• Nikoskelainen J, Hannuksela M, Palva T. Antibodies to Epstein-Barr virus and some other herpesviruses in patients with sarcoidosis, pulmonary tuberculosis and erythema nodosum. Scand J Infect Dis. 1974;6(3):209–216.
   PubMed Web of Science ®Google Scholar
• Eishi Y. Etiologic link between sarcoidosis and Propionibacterium acnes. Respir Investig. 2013;51(2):56–68.
   PubMedGoogle Scholar
• Negi M, Takemura T, Guzman J, et al. Localization of propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium. Mod Pathol. 2012;25(9):1284–1297.
   PubMed Web of Science ®Google Scholar
• Ishige I, Usui Y, Takemura T, et al. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet. 1999;354(9173):120–123.
   Web of Science ®Google Scholar
• Yamada T, Eishi Y, Ikeda S, et al. In situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition. J Pathol. 2002;198(4):541–547.
   PubMed Web of Science ®Google Scholar
• Ishige I, Eishi Y, Takemura T, et al. Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2005;22(1):33–42.
   Web of Science ®Google Scholar
• Yasuhara T, Tada R, Nakano Y, et al. The presence of Propionibacterium spp. in the vitreous fluid of uveitis patients with sarcoidosis. Acta Ophthalmol Scand. 2005;83(3):364–369.
   Google Scholar
• Goto H, Usui Y, Umazume A, et al. Propionibacterium acnes as a possible pathogen of granuloma in patients with ocular sarcoidosis. Br J Ophthalmol. 2017;101(11):1510–1513.
   PubMed Web of Science ®Google Scholar
• Nagata K, Eishi Y, Uchida K, et al. Immunohistochemical Detection of Propionibacterium acnes in the Retinal Granulomas in Patients with Ocular Sarcoidosis. Sci Rep. 2017;7(1):15226:
   PubMed Web of Science ®Google Scholar
• Statement on sarcoidosisJoint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736–755.
   PubMed Web of Science ®Google Scholar
• Asukata Y, Ishihara M, Hasumi Y, et al. Guidelines for the diagnosis of ocular sarcoidosis. Ocul Immunol Inflamm. 2008;16(3):77–81.
   PubMed Web of Science ®Google Scholar
• Shijubo N, Yamaguchi T. Diagnosis criteria and classification of disease severity for sarcoidosis in Japan. JJSOGD. 2015;35(1):3–8.
   Google Scholar
• Yamamoto M. The concept, definition and diagnostic criteria of sarcoidosis (in Japanese, with English abstract. Nihon Rinsho. 1994;52(6):1426–1432. ).
   Google Scholar
• Consensus statements for the management of sarcoidosis 2020. by Japan Society of Sarcoidosis and other Granulomatous Disorders (in Japanese). https://wwwjssogcom/wp/wp-content/themes/jssog/images/system/guidance/2-4-2pdf.
   Google Scholar
• Herbort CP, Rao NA, Mochizuki M. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17:160–169.
   PubMed Web of Science ®Google Scholar
• Takase H, Shimizu K, Yamada Y, et al. Validation of international criteria for the diagnosis of ocular sarcoidosis proposed by the first international workshop on ocular sarcoidosis. Jpn J Ophthalmol. 2010;54(6):529–536.
   PubMed Web of Science ®Google Scholar
• Jones NP. Liver function testing is not useful in the diagnosis of sarcoidosis in patients presenting with uveitis. Ocul Immunol Inflamm. 2017;25(3):333–337.
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Smith JR, Takase H, International Workshop on Ocular Sarcoidosis Study Group, et al. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019;103(10):1418–1422.
   PubMed Web of Science ®Google Scholar
• Handa-Miyauchi M, Takase H, Tanaka M, et al. A Validation Study of the Revised Diagnostic Criteria from the International Workshop on Ocular Sarcoidosis at a Single Institute in Japan. Ocul Immunol Inflamm. 2020. DOI:https://doi.org/10.1080/09273948.2020.1758159.
   Google Scholar
• Babu K, Shukla SB, Philips M. High resolution chest computerized tomography in the diagnosis of ocular sarcoidosis in a high TB endemic population. Ocul Immunol Inflamm. 2017;25(2):253–258.
   PubMed Web of Science ®Google Scholar
• Ohara K, Okubo A, Kamata K, et al. Transbronchial lung biopsy in the diagnosis of suspected ocular sarcoidosis. Arch Ophthalmol. 1993;111(5):642–644.
   Google Scholar
• Takase H, Acharya NR, Babu K, et al. Recommendations for the management of ocular sarcoidosis from the International Workshop on Ocular Sarcoidosis. Br J Ophthalmol. 2020. DOI:https://doi.org/10.1136/bjophthalmol-2020-317354.
   Google Scholar
• Reich JM. Corticosteroid therapy and relapse in sarcoidosis. Chest. 1998;113(2):559–561.
   Google Scholar
• Palestine AG, Nussenblatt RB, Chan CC. Treatment of intraocular complications of sarcoidosis. Ann N Y Acad Sci. 1986;465:564–574.
   Web of Science ®Google Scholar
• Mayer GN, Longo M, Gomes BB, et al. Low dose corticosteroid in association with methotrexate for therapy of ocular sarcoidosis: report of a case. Int J Retina Vitreous. 2015;1:7.
   Google Scholar
• Baughman RP, Lower EE, Kaufman AH. Ocular sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):452–462.
   PubMed Web of Science ®Google Scholar
• Cremers JP, Drent M, Bast A, et al. Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide. Curr Opin Pulm Med. 2013;19(5):545–561.
   PubMed Web of Science ®Google Scholar
• Jaffe GJ, Dick AD, Brezin AP, et al. Adalimumab in patients with active noninfectious uveitis. N Engl J Med. 2016;375(10):932–943.
   PubMed Web of Science ®Google Scholar
• Nguyen QD, Merrill PT, Jaffe GJ, et al. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet. 2016;388(10050):1183–1192.
   PubMed Web of Science ®Google Scholar
• Suhler EB, Adan A, Brezin AP, et al. Safety and efficacy of adalimumab in patients with noninfectious uveitis in an ongoing open-label study: VISUAL III. Ophthalmology. 2018;125(7):1075–1087.
   PubMed Web of Science ®Google Scholar
• Riancho-Zarrabeitia L, Calvo-Rio V, Blanco R, et al. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients. Semin Arthritis Rheum. 2015;45(3):361–368.
   PubMed Web of Science ®Google Scholar
• Erckens RJ, Mostard RL, Wijnen PA, et al. Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol. 2012;250(5):713–720.
   PubMed Web of Science ®Google Scholar
• Drent M, Cremers JP, Jansen TL, et al. Practical eminence and experience-based recommendations for use of TNF-alpha inhibitors in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31(2):91–107.
   PubMed Web of Science ®Google Scholar
• Massara A, Cavazzini L, La Corte R, et al. Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new "class effect" paradoxical phenomenon. Two case reports and literature review. Semin Arthritis Rheum. 2010;39(4):313–319.
   PubMed Web of Science ®Google Scholar
• Akova YA, Foster CS. Cataract surgery in patients with sarcoidosis-associated uveitis. Ophthalmology. 1994;101(3):473–479.
   Web of Science ®Google Scholar
• Razeghinejad MR, Katz LJ. Steroid-induced iatrogenic glaucoma. Ophthalmic Res. 2012;47(2):66–80.
   PubMed Web of Science ®Google Scholar
• Hamanaka T, Takei A, Takemura T, et al. Pathological study of cases with secondary open-angle glaucoma due to sarcoidosis. Am J Ophthalmol. 2002;134(1):17–26.
   Web of Science ®Google Scholar
• Maitra P, Kumar DA, Agarwal A. Epiretinal membrane profile on spectral domain optical coherence tomography in patients with uveitis. Indian J Ophthalmol. 2019;67(3):376–381.
   Web of Science ®Google Scholar
• Takai N, Kobayashi T, Kida T, et al. Clinical features of Japanese patients with ocular inflammation and their surgical procedures over the course of 20 years. Clin Ophthalmol. 2020;14:2799–2806.
   Web of Science ®Google Scholar
• Kiryu J, Kita M, Tanabe T, et al. Pars plana vitrectomy for epiretinal membrane associated with sarcoidosis. Jpn J Ophthalmol. 2003;47(5):479–483.
   PubMed Web of Science ®Google Scholar
• Kiryu J, Kita M, Tanabe T, et al. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis. Ophthalmology. 2001;108(6):1140–1144.
   PubMed Web of Science ®Google Scholar
• Takayama K, Tanaka A, Shibata M, et al. Evaluation of microincision vitrectomy surgery using wide-viewing system for complications with ocular sarcoidosis. Medicine (Baltimore). 2015;94(7):e559:
   Web of Science ®Google Scholar
• Mochizuki M, Sugita S, Kamoi K, et al. A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases. Jpn J Ophthalmol. 2017;61(1):1–20.
   PubMed Web of Science ®Google Scholar
• Sugita S, Takase H, Sugamoto Y, et al. Diagnosis of intraocular lymphoma by polymerase chain reaction analysis and cytokine profiling of the vitreous fluid. Jpn J Ophthalmol. 2009;53(3):209–214.
   Web of Science ®Google Scholar
• Maruyama K, Inaba T, Tamada T, et al. Vitreous lavage fluid and bronchoalveolar lavage fluid have equal diagnostic value in sarcoidosis. Medicine (Baltimore). 2016;95(49):e5531:
   PubMed Web of Science ®Google Scholar